September 4, 2008
Quinnova Pharmaceuticals, Inc. Announces Appointment of Senior Vice President of Research & Development
Quinnova Pharmaceuticals, Inc. announced today the appointment of Dr. Christopher Hensby as Senior Vice President Research & Development. Dr. Hensby will assume his new post starting in October of 2008.
Dr. Hensby is a graduate BSc. in Pharmacology from Kings College, London and researched his PhD at Edinburgh University. He began his career in Dermatology in 1975 when he joined Professor Malcolm Greaves at the Institute of Dermatology, St John's Hospital, London, where he established a new department of Skin Pharmacology. In 1977, he joined Sir Colin Dollery at the Royal Postgraduate Medical School, London University, in the department of Clinical Pharmacology, to continue his research into inflammatory disorders.
"We are extremely pleased to have another leader of Chris's caliber join the Quinnova management team," said Jeffrey Day, President & CEO. "He brings expertise both in the development of products in Dermatology and Podiatry markets plus compliance in International Clinical and Regulatory Affairs."
About Quinnova Pharmaceuticals, Inc.
Quinnova Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drug products based on innovative topical drug delivery platforms. For more information, please visit www.quinnova.com.